Latin America’s market for autologous fat grafting is anticipated to witness ~17% CAGR through 2029.
[USPRwire, Fri Sep 20 2019] The report studies the autologous fat grafting market worldwide, especially in North America, Europe, Southeast Asia, India and Other Regions with production, size, growth, revenue, consumption, import and export in these regions. In order to study the various trends and patterns prevailing in the concerned market, Fact.MR has included a new report on autologous fat grafting market to its wide online database including upcoming trends and market growth factors through 2029. This research assessment offers a clear insight about the influential factors that are expected to transform the global market in the near future.The insights structured for presenting the target market are procured from both primary research and secondary research, and are utilized for validation that is valuable to investors, manufacturers and new entrants.
Get A Sample Copy of Market Report Here - https://www.factmr.com/connectus/sample?flag=S&rep_id=2701
Demand for autologous fat grafting procedures accounted for the revenues worth US$ 317 Mn, in 2018. Continued preference for the use of non-invasive aesthetic techniques in skin rejuvenation is primarily favoring the growth of autologous fat grafting market. ~14% CAGR has been projected for the autologous fat grafting market over 2019-2029, which is prominently estimated to be driven by the increasing social acceptance of aesthetic cosmetic procedures. North America is anticipated to remain the leading market for autologous fat grafting during the forecast period. Latin America’s market for autologous fat grafting is anticipated to witness ~17% CAGR through 2029.
The four leading companies that account for the consolidation of the competition landscape of autologous fat grafting market, continue to represent a whopping 80% share in the revenues. Allergan, MicroAire, Alma Lasers, and Human Med are expected to primarily maintain their strategic focus on partnerships and acquisitions with smaller yet active players. The latter are typically specialized in the development of meniscus repair systems for treating meniscal scars. With this, leading companies operating in autologous fat grafting industry, are eyeing feasibility of entry in the meniscal scars treatment landscape. Increasing strategic tie-ups among manufacturers of systems & accessories, and recognized research institutions, aim to ensure sufficient device supply and superior post-sales service.
Manufacturers in the autologous fat grafting market are also investing efforts in introducing innovative products, to enhance their market shares. For instance, in 2019, Alma Lasers (Sisram Medical) announced the availability of BeautiFill as the novel laser-based technique for fat harvesting, while leveraging autologous fat to restore the volume to body or face. As cellular therapies are increasingly being perceived as mainstream therapeutic option, there has been a surge in demand for adipose derived stem cells (ADSC), which is potentially applicable in tissue engineering and regeneration. Additionally, a growing focus of leading players on introducing advanced systems & accessories is likely to extend applicability of their offerings, leveraging untapped opportunities in the autologous fat grafting market.
Key Factors Shaping Autologous Fat Grafting Market